Dr. Lehman Discusses the Use of Breast MRI

Constance D. Lehman, MD, PhD
Published: Monday, Jun 10, 2013

Constance D. Lehman, MD, PhD, Vice Chair, Radiology Department, University of Washington School of Medicine, Medical Director, Imaging, Seattle Cancer Care Alliance, discusses the use of breast MRI.

Breast MRI is often used in patients with high-risk disease for screening purposes. Research has demonstrated that node-positive disease can be all but completely eliminated in patients at high risk when screened annually with breast MRI. This is exciting news, Lehman says.

Breast MRI is also used in patients who have been recently diagnosed with breast cancer. This is a controversial area, Lehman says. Research is being conducted to better understand how to use breast MRI in the pre-operative setting as well as the potential benefits and risks.

<<< View more from the 2013 ASCO Annual Meeting

Constance D. Lehman, MD, PhD, Vice Chair, Radiology Department, University of Washington School of Medicine, Medical Director, Imaging, Seattle Cancer Care Alliance, discusses the use of breast MRI.

Breast MRI is often used in patients with high-risk disease for screening purposes. Research has demonstrated that node-positive disease can be all but completely eliminated in patients at high risk when screened annually with breast MRI. This is exciting news, Lehman says.

Breast MRI is also used in patients who have been recently diagnosed with breast cancer. This is a controversial area, Lehman says. Research is being conducted to better understand how to use breast MRI in the pre-operative setting as well as the potential benefits and risks.

<<< View more from the 2013 ASCO Annual Meeting




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x